IGF1 and breast carcinoma: Mechanistically, studies have demonstrated that the PI3K/Akt signaling pathway mediates the biological effects of insulin and insulin-like growth factor-1 (IGF-1), and is aberrantly activated in diabetes/impaired glucose tolerance (IGT), obesity, and breast cancer, suggesting a potential link among these comorbidities [42].